Couchoud Cécile, Savoye Emilie, Frimat Luc, Ryckelynck Jean-Philippe, Chalem Ylana, Verger Christian
The French REIN Registry, National Coordinating Centre, Biomedicine Agency, Saint-Denis La Plaine, France.
Perit Dial Int. 2008 Sep-Oct;28(5):509-17.
In France, the use of peritoneal dialysis (PD) as the first-choice treatment varies greatly between districts, as it is already known to do between countries. Baseline clinical factors associated with choice of first modality were analyzed in 10 815 new end-stage renal disease patients in 59 districts. To describe practices at the district level, we used an agglomerative hierarchical classification, with proximity defined by a likelihood-ratio test that compared multivariate logistic regressions of the following factors: age, gender, diabetes, congestive heart failure, severe behavioral disorders, mobility, and employment. To propose a typology, each cluster of districts was described by a multivariate logistic regression. While populations starting PD in France, as elsewhere, are more likely to be young or employed, they are also more likely to be elderly or have congestive heart failure or severe behavioral disorders. Overall, 14% of patients start with PD, but this rate varies significantly across districts, from 0% to 45%. A specific combination of factors was associated with the first-choice modality in each group of districts. This study highlights the lack of consensual medical criteria for this choice and the likelihood that nonmedical factors may explain the observed differences. The high variability suggests that PD can be used in almost all clinical conditions. Accordingly, patient preference should play a more important role in the decision-making process.
在法国,腹膜透析(PD)作为首选治疗方式的使用情况在不同地区差异很大,正如在不同国家之间所知的那样。我们对59个地区的10815例新的终末期肾病患者分析了与首选治疗方式相关的基线临床因素。为了描述地区层面的治疗情况,我们使用了凝聚层次分类法,其相近性由似然比检验定义,该检验比较了以下因素的多变量逻辑回归:年龄、性别、糖尿病、充血性心力衰竭、严重行为障碍、活动能力和就业情况。为了提出一种类型学,每个地区集群都通过多变量逻辑回归进行描述。在法国,开始接受腹膜透析治疗的人群与其他地方一样,更有可能是年轻人或有工作,但他们也更有可能是老年人,或患有充血性心力衰竭或严重行为障碍。总体而言,14%的患者开始时接受腹膜透析治疗,但这一比例在不同地区差异显著,从0%到45%不等。每组地区中,特定的因素组合与首选治疗方式相关。这项研究凸显了在这一选择上缺乏共识性的医学标准,以及非医学因素可能解释所观察到的差异的可能性。高度的变异性表明腹膜透析几乎可用于所有临床情况。因此,患者偏好应在决策过程中发挥更重要的作用。